The U.S. Food and Drug Administration published a report to justify authorizing COVID-19 vaccines for infants and toddlers, but the report is just more of the same: exaggerating the risk of the virus and minimizing the perception of the risk posed by the vaccines.
The U.S. Food and Drug Administration’s vaccine advisory council will meet June 14 to consider granting Emergency Use Authorization (EUA) of the Pfizer and Moderna COVID-19 vaccines for children under 5 years old, even though the White House last week announced it is already filling orders for the vaccines placed by states and healthcare providers. Click here to tell your members of Congress to oppose EUA of these vaccines for young children.
As promised, the U.S. Food and Drug Administration (FDA) has ginned up a report that ostensibly will be used to try to justify “approval” (whatever they mean by that now) of COVID-19 vaccines for infants and toddlers (children < 5 years old).
It is not hard to see what shenanigans the FDA has been up to — to try to bolster a vaccine that fewer and fewer adults want. It’s more of the same: exaggerating the apparent risk of the virus and minimizing the perception of risk posed by the vaccines.
In other words, lies.
1. There is no evidence of clinical urgency.
Infants and toddlers (and children in general) do not get COVID-19; they do not (yet) die from COVID-19.